People

  1. Chang
    Chang
  2. Guo
    Guo
  3. Sirotnak
    Sirotnak
  4. Cadete Portelinha
    Cadete Portelinha
  5. Sarkar
    Sarkar
  6. Moskowitz
    Moskowitz
  7. Diplas
    Diplas
  8. Lipitz Snyderman
    Lipitz Snyderman
  9. Carver
    Carver
  10. Cordeiro
    Cordeiro
  11. Andretta
    Andretta
  12. Ganesh
    Ganesh
  13. Zalavadia
    Zalavadia
  14. Ricart Arbona
    Ricart Arbona
  15. Mueller
    Mueller

Recent Works

  1. CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  2. Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
    Meeting Abstract

    Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  3. PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7
    Meeting Abstract

    Kunimoto, H.; Honma, D.; Tsutsumi, S.; Sakuma, T.; Ohashi, T.; Teranaka, H.; Ikeda, J.; Toya, T.; Harada, Y.; Doki, N.; more...
    Cancer Science (2025)

    Fulltext@MSK | Save